Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 PALMIN CERTIFICATION PURSUANT TO SEC 906 - Acer Therapeutics Inc. | acer-ex322_163.htm |
| EX-32.1 - EX-32.1 SCHELLING CERTIFICATION PURSUANT TO SEC 906 - Acer Therapeutics Inc. | acer-ex321_164.htm |
| EX-31.2 - EX-31.2 PALMIN CERTIFICATION PURSUANT TO SEC 302 - Acer Therapeutics Inc. | acer-ex312_165.htm |
| EX-31.1 - EX-31.1 SCHELLING CERTIFICATION PURSUANT TO SEC 302 - Acer Therapeutics Inc. | acer-ex311_166.htm |
| EX-23.1 - EX-23.1 AUDITORS CONSENT - Acer Therapeutics Inc. | acer-ex231_162.htm |
| EX-10.19 - EX-10.19 SUBLEASE AND CONSENT - Acer Therapeutics Inc. | acer-ex1019_281.htm |
| 10-K - 10-K - Acer Therapeutics Inc. | acer-10k_20171231.htm |
Exhibit 21.1
SUBSIDIARIES OF THE REGISTRANT
Listed below are subsidiaries of Acer Therapeutics Inc. as of December 31, 2017.
|
Subsidiary Name |
|
State/Jurisdiction of Incorporation |
|
|
|
|
|
Acer Therapeutics Inc. |
|
Delaware |